Sections from the nodular area on microscopy showed marked atrophy of the glandular tissue, extensive lymphoplasmacytic infiltrate with the presence of lymphoid follicles and large areas of fibrosis [ Figure 2a ]. Few areas with storiform pattern of fibrosis were seen [ Figure 2b ]. Obliterative phlebitis was noted with few eosinophils in the vessel wall along with lymphocytes, plasma cells and fibrosis [ Figure 2c ]. Section from the relatively normal-appearing salivary gland showed some preserved glandular parenchyma along with few lymphoid follicles. Immunohistochemistry for IgG4 was done which came out to be positive in >150 plasma cells per high-power field [ Figure 2d ].
DISCUSSION
In 1892, Dr. Johann von Mikulicz described a patient with lacrimal, parotid and submandibular gland enlargement with fibrosis and named it "Mikulicz's disease." [4] In 1896, Dr. Hermann Küttner described a patient with a tumor-like lesion exclusively of the submandibular gland with very severe fibrous sclerotic tissue and named it "Küttner's tumor." [3] Both these lesions have similar features on histopathology. Many workers in recent studies have found these lesions to contain increased IgG4-positive plasma cells. [2, 5, 6] Therefore, IgG4-related chronic sclerosing sialadenitis is said to encompass many previously diagnosed cases of Mikulicz's disease and Küttner's tumor.
IgG4-RD forms a distinct, novel, clinically independent disease category which is not very rare and is attracting clinical attention as a new entity. Many questions and problems still remain to be elucidated, including its pathogenesis and the role of IgG4. The various organs with the corresponding diseases in which IgG4-positive plasma cell infiltration has been observed are listed in Table 1 . [7] The histopathologic diagnostic criteria for IgG4-positive Mikulicz's disease/IgG4-positive chronic sclerosing sialadenitis approved by Japanese Society for SjÖgren's Syndrome (2008) were lymphocyte and IgG4 + plasma cell infiltration (IgG4 + plasma cells/IgG + plasma cells ratio >50%) with typical tissue fibrosis. [8] Recently, according to the Consensus Statement on the Pathology (2012) of IgG4-RD, three histopathological features necessary for their diagnosis (other than in lymph nodes) are dense lymphoplasmacytic infiltrate (often with mild eosinophilia), storiform pattern of fibrosis and obliterative phlebitis. If only 1 or 2 histopathological features are present, then for diagnosis, the tissue IgG4 counts are considered which vary for different organs, for example, in pancreas, liver and kidney biopsy; it is >10/hpf, while for salivary gland, lacrimal gland and lymph node, the IgG4 count should be >100/hpf. [9] In our study, >150 IgG4-positive plasma cells per high-power field were seen along with storiform pattern of fibrosis and obliterative phlebitis [ Figure 2 ].
Close differential diagnoses of IgG4-related chronic sclerosing sialadenitis include chronic sialadenitis and SjÖgren's syndrome. Chronic sialadenitis does not have storiform pattern of fibrosis or obliterative phlebitis. SjÖgren's syndrome is associated with xerostomia, xerophthalmia and glandular destruction. Furthermore, it is characterised by increased antinuclear antibodies such as anti-Sjögren'ssyndrome-related antigen A (anti-SSA) and is also said to be unresponsive to steroids. [10] FNAC of the IgG4 lesions is usually nonconclusive. [11] In our case also, it was noncontributory. Sometimes, the complete histological picture may not be represented on needle biopsy samples also. Therefore, clinicians must consider IgG4-RD as a differential diagnosis in cases of any mass lesion.
Serum IgG4 levels are elevated in majority of the cases of IgG4-RD. Umehara et al. have mentioned about elevated serum IgG4 levels >135 mg/dl to be considered as one of the diagnostic clinical criteria. [8] However, these levels are also elevated in vasculitis, sarcoidosis, primary sclerosing cholangitis, liver cirrhosis and allergies. [12] In our case, serum IgG4 level was not done.
Around 30% of the patients undergo spontaneous remissions. Similar numbers of patients may also have relapse. Rapid induction of therapy using glucocorticoids is the first line of treatment. Significant improvement in the gland size and function has been observed, although few cases may be refractory to treatment. [13] Rarely, these lesions have been associated with the development of marginal zone B-cell lymphoma and salivary duct carcinoma. [14, 15] A case of adenoid cystic carcinoma arising in a background of this disease has also been reported; however, more studies are needed to establish a definitive risk for such complications. [16] We present this case to highlight the histopathological features of this considerably new entity as its treatment protocol, disease progression and prognosis differ from that of chronic sialadenitis and SjÖgren's syndrome.
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